Increase in prevalence and costs of cirrhosis in the Netherlands: a nationwide hospital diagnosis data analysis
The prevalence of patients with cirrhosis registered as a patient in Dutch hospitals increased by more than 50 percent from 2017 to 2021, with regional differences. Consequently, total healthcare costs for Dutch patients with cirrhosis more than doubled in less than 5 years.
Authors
- R. Bart Takkenberg
- Frans J.C. Cuperus (ORCID: https://orcid.org/0000-0001-6742-1510)
- Raoel Maan (ORCID: https://orcid.org/0000-0001-6402-398X)
- Marten A. Lantinga (ORCID: https://orcid.org/0000-0003-3137-901X)
- Diederick J. van Doorn (ORCID: https://orcid.org/0000-0003-3299-0654)
- Gwen Masclee (ORCID: https://orcid.org/0000-0002-2839-027X)
- Minneke J. Coenraad (ORCID: https://orcid.org/0000-0002-3434-4421)
- Koos de Wit (ORCID: https://orcid.org/0000-0001-8472-8549)
- Hanneke van Soest
- Matthijs Kramer
Institutions
- University Medical Center Groningen (NL)
- Leiden University Medical Center (NL)
- Maastricht University Medical Centre (NL)
- Medisch Centrum Haaglanden (NL)
- Amsterdam University Medical Centers (NL)
- University of Amsterdam (NL)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- European Journal of Gastroenterology & Hepatology
- Published
- 2024-12-11
- DOI
- https://doi.org/10.1097/meg.0000000000002905
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.39